Stocks to sell

Sometimes, investors want to diversify their portfolios geographically. Consequently, they might be curious about StoneCo (NASDAQ:STNE), a financial technology (fintech) firm that’s based in Brazil. It’s fine to research STNE stock, but this doesn’t mean that you should actually own it. Source: Shutterstock For one thing, the latest news reports regarding StoneCo are filled with class-action
0 Comments
I’d highly discourage you from investing in Peloton Interactive (NASDAQ:PTON) stock no matter what you hear about its possible turnaround. Source: JHVEPhoto / Shutterstock.com With the rise of the new Omicron variant, many investors may be looking to edge towards heavier portfolio allocation in “stay-at-home stocks.” Whether this would be a good move or not
0 Comments
Rivian Automotive’s (NASDAQ:RIVN) management deserves praise for listing RIVN stock at the perfect moment as the stock shot to $180. Source: James Yarbrough / Shutterstock.com Rivian management’s celebration proved short-lived. The next day after the peak, sellers emerged. Despite the drop, RIVN stock could see ~ $180 again if investors look at what brought the stock
0 Comments
Chegg (NYSE:CHGG), which provides online education tools to students, recently reported disappointing third-quarter results, and the company is facing very steep macro challenges. Despite the sharp decline of CHGG stock, its valuation remains elevated, given the firm’s growth outlook, its macro issues and the relatively low barriers to entry in its sector. Source: Casimiro PT
0 Comments
I recommended Moderna (NASDAQ:MRNA) stock in late 2020 as part of a decade-long trend.  But MRNA stock has been taken over by events surrounding the company’s COVID-19 vaccine. Source: Shutterstock Through the first three quarters of 2021, Moderna racked up $11.26 billion in sales. Analysts expect another $5.9 billion to come rolling in for Q4.
0 Comments
In recent weeks, QuantumScape (NYSE:QS) has made significant progress, improving the company’s outlook. Still, the valuation of QS stock remains very high, and the company continues to face major risks. Source: Michael Vi / Shutterstock.com Among these risks, as Morgan Stanley recently pointed out, are tough competition and the possibility that the production of electric
0 Comments
Deciphera Pharmaceuticals (NASDAQ:DCPH) is a biotech company that develops drugs mainly for the treatment of cancer. Right now, DCPH stock shares are down nearly 85% year-to-date (YTD), at $7.70 as of the close of Nov. 29. Source: Iryna Imago / Shutterstock.com Of course, with Thanksgiving just over, it’s probably appropriate to note that I’m thankful for
0 Comments
When you chase after a stock that has gone too far without justification, you’re likely to get punished. That’s a lesson learned by many of Jumia Technologies’ (NYSE:JMIA) shareholders, as JMIA stock has been taking a beating lately. Source: farzand01 / Shutterstock.com As the old saying goes, the trend is your friend. There’s nothing friendly about
0 Comments
SoFi Technologies (NASDAQ:SOFI) is a fintech company seeking to disrupt the traditional banking market. SOFI stock officially launched earlier this year after it completed a merger with one of Chamath Palihapitiya’s special purpose acquisition companies (SPACs). Source: rafapress / Shutterstock.com Out of the gate, SoFi generated a lot of excitement. Unlike some of its fintech
0 Comments
For the last few months I have been warning investors away from Vinco Ventures (NASDAQ:BBIG) stock. Since my first story came out in September, the shares are down 67%. They closed November 23 at $3.13. Source: shutterstock.com/Postmodern Studio My problem with the company is that there is nothing there. It’s all hype and buzzwords like streaming
0 Comments